Greg Carney
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 4
-
- Diabetes Treatment and Management 5
- Co-authors
- Colin R. Dormuth (32 shared papers)Kenneth L Bassett (20 shared papers)James M Wright (9 shared papers)Sebastian Schneeweiß (4 shared papers)Jeffrey Neil Katz (1 shared paper)Michael E. Weinblatt (1 shared paper)Daniel H. Solomon (1 shared paper)Robert J. Glynn (1 shared paper)
- Journals
- CMAJ Open (5 papers)Value in Health (3 papers)Pharmacoepidemiology and Drug Safety (3 papers)Canadian Medical Association Journal (2 papers)PLoS ONE (2 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Greg Carney
36 papers receiving 644 citations
Peers
Comparison fields: 5 of 67
- Rheumatology 150
- Geriatrics and Gerontology 33
- Orthopedics and Sports Medicine 74
- Endocrinology, Diabetes and Metabolism 96
- Toxicology 27
Countries citing papers authored by Greg Carney
This map shows the geographic impact of Greg Carney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Carney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Carney more than expected).
Fields of papers citing papers by Greg Carney
This network shows the impact of papers produced by Greg Carney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Carney. The network helps show where Greg Carney may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Carney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 217 | |
| 2 | 2009 | 113 | |
| 3 | 2016 | 49 | |
| 4 | 2012 | 24 | |
| 5 | 2022 | 23 | |
| 6 | 2011 | 21 | |
| 7 | 2015 | 21 | |
| 8 | 2017 | 21 | |
| 9 | 2009 | 20 | |
| 10 | Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis. | 2008 | 19 |
| 11 | 2020 | 18 | |
| 12 | 2006 | 16 | |
| 13 | 2020 | 13 | |
| 14 | 2016 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 10 | |
| 18 | Impact of rosiglitazone meta-analysis on use of glucose-lowering medications. | 2010 | 8 |
| 19 | 2011 | 8 | |
| 20 | 2022 | 8 |
About Greg Carney
Greg Carney is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism, Pharmacology, Orthopedics and Sports Medicine and Public Health, Environmental and Occupational Health, having authored 40 papers that have together received 698 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Healthcare cost, quality, practices (4 papers), Opioid Use Disorder Treatment (4 papers), Bone health and osteoporosis research (3 papers), Smoking Behavior and Cessation (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). The work is most often cited by research in Rheumatology (150 citations), Geriatrics and Gerontology (33 citations), Orthopedics and Sports Medicine (74 citations), Endocrinology, Diabetes and Metabolism (96 citations) and Toxicology (27 citations). Greg Carney has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Colin R. Dormuth, Kenneth L Bassett, James M Wright, Sebastian Schneeweiß, Jeffrey Neil Katz, Michael E. Weinblatt, Daniel H. Solomon, Robert J. Glynn, Earl Francis Cook and Soko Setoguchi. Their work appears in journals such as CMAJ Open, Value in Health, Pharmacoepidemiology and Drug Safety, Canadian Medical Association Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.